241 related articles for article (PubMed ID: 17177309)
1. Chimeric HIV-1 and HIV-2 lentiviral vectors with added safety insurance.
Sachdeva G; D'Costa J; Cho JE; Kachapati K; Choudhry V; Arya SK
J Med Virol; 2007 Feb; 79(2):118-26. PubMed ID: 17177309
[TBL] [Abstract][Full Text] [Related]
2. Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usage.
Strappe PM; Hampton DW; Brown D; Cachon-Gonzalez B; Caldwell M; Fawcett JW; Lever AM
Retrovirology; 2005 Sep; 2():55. PubMed ID: 16168051
[TBL] [Abstract][Full Text] [Related]
3. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.
Wagner R; Graf M; Bieler K; Wolf H; Grunwald T; Foley P; Uberla K
Hum Gene Ther; 2000 Nov; 11(17):2403-13. PubMed ID: 11096444
[TBL] [Abstract][Full Text] [Related]
4. Production of lentiviral vectors for transducing cells from the central nervous system.
Li M; Husic N; Lin Y; Snider BJ
J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel trans-lentiviral vector that affords predictable safety.
Wu X; Wakefield JK; Liu H; Xiao H; Kralovics R; Prchal JT; Kappes JC
Mol Ther; 2000 Jul; 2(1):47-55. PubMed ID: 10899827
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation.
D'Costa J; Brown HM; Kundra P; Davis-Warren A; Arya SK
J Gen Virol; 2001 Feb; 82(Pt 2):425-434. PubMed ID: 11161282
[TBL] [Abstract][Full Text] [Related]
7. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O; Berkhout B
J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
[TBL] [Abstract][Full Text] [Related]
9. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing the titer and infectivity of lentiviral vectors.
Logan AC; Nightingale SJ; Haas DL; Cho GJ; Pepper KA; Kohn DB
Hum Gene Ther; 2004 Oct; 15(10):976-88. PubMed ID: 15585113
[TBL] [Abstract][Full Text] [Related]
11. Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo.
Park F; Kay MA
Mol Ther; 2001 Sep; 4(3):164-73. PubMed ID: 11545606
[TBL] [Abstract][Full Text] [Related]
12. Analysis of lenti- and trans-lentiviral vector genetic recombination.
Wu X; Wakefield JK; Liu H; Kappes JC
Dev Biol (Basel); 2001; 106():237-48; discussion 249, 253-63. PubMed ID: 11761237
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: expression and potential for helper virus-free packaging.
Arya SK; Zamani M; Kundra P
Hum Gene Ther; 1998 Jun; 9(9):1371-80. PubMed ID: 9650621
[TBL] [Abstract][Full Text] [Related]
14. A new-generation stable inducible packaging cell line for lentiviral vectors.
Farson D; Witt R; McGuinness R; Dull T; Kelly M; Song J; Radeke R; Bukovsky A; Consiglio A; Naldini L
Hum Gene Ther; 2001 May; 12(8):981-97. PubMed ID: 11387062
[TBL] [Abstract][Full Text] [Related]
15. HIV-1-based lentiviral vectors.
Liu YP; Berkhout B
Methods Mol Biol; 2014; 1087():273-84. PubMed ID: 24158830
[TBL] [Abstract][Full Text] [Related]
16. HIV-2 derived lentiviral vectors: gene transfer in Parkinson's and Fabry disease models in vitro.
D'Costa J; Harvey-White J; Qasba P; Limaye A; Kaneski CR; Davis-Warren A; Brady RO; Bankiewicz KS; Major EO; Arya SK
J Med Virol; 2003 Oct; 71(2):173-82. PubMed ID: 12938190
[TBL] [Abstract][Full Text] [Related]
17. Mapping of the bovine immunodeficiency virus packaging signal and RRE and incorporation into a minimal gene transfer vector.
Molina RP; Matukonis M; Paszkiet B; Zhang J; Kaleko M; Luo T
Virology; 2002 Dec; 304(1):10-23. PubMed ID: 12490399
[TBL] [Abstract][Full Text] [Related]
18. A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors.
Cockrell AS; Ma H; Fu K; McCown TJ; Kafri T
Mol Ther; 2006 Aug; 14(2):276-84. PubMed ID: 16516556
[TBL] [Abstract][Full Text] [Related]
19. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
[TBL] [Abstract][Full Text] [Related]
20. Safety considerations in vector development.
Kappes JC; Wu X
Somat Cell Mol Genet; 2001 Nov; 26(1-6):147-58. PubMed ID: 12465466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
